{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:55:16Z","timestamp":1774608916882,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1007\/s10016-003-0080-4","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T17:20:41Z","timestamp":1083259241000},"page":"237-242","source":"Crossref","is-referenced-by-count":15,"title":["A Case of Warfarin Skin Necrosis Despite Enoxaparin Anticoagulation in a Patient with Protein S Deficiency"],"prefix":"10.1016","volume":"18","author":[{"given":"Chau Y.","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Ierardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10016-003-0080-4_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archinte.1993.00410130045005","article-title":"Subcutaneous low-molecular-weight-heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis","volume":"153","author":"Simonneau","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1007\/s10016-003-0080-4_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of lowmolecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1007\/s10016-003-0080-4_bib3","first-page":"121","article-title":"Thrombophlebitis migrans disseminata: report of a case in which gangrene of a breast occurred","volume":"43","author":"Flood","year":"1943","journal-title":"N.Y. State J. Med."},{"key":"10.1007\/s10016-003-0080-4_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<233::AID-AJH10>3.0.CO;2-B","article-title":"Late-onset warfarin-induced skin necrosis: case report and review of the literature","volume":"57","author":"Essex","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1007\/s10016-003-0080-4_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0038-1657628","article-title":"Warfarin and heparininduced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment","volume":"78","author":"Sallah","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1007\/s10016-003-0080-4_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0190-9622(86)70096-0","article-title":"Acral purpura: an unusual sign of warfarin necrosis","volume":"14","author":"Stone","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1007\/s10016-003-0080-4_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0190-9622(87)80191-3","article-title":"Coumadin versus heparin necrosis [letter]","volume":"16","author":"Gold","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1007\/s10016-003-0080-4_bib8","series-title":"Histopathology of the Skin","first-page":"186","author":"Lever","year":"1990"},{"key":"10.1007\/s10016-003-0080-4_bib9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archderm.1986.01660240072019","article-title":"Recurrent coumarin-induced skin necrosis in a patient with an acquired functional protein C deficiency","volume":"122","author":"Teepe","year":"1986","journal-title":"Arch. Dermatol."},{"key":"10.1007\/s10016-003-0080-4_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bmj.298.6668.233","article-title":"Necrosis of skin induced by warfarin in a patient deficient in protein S.","volume":"298","author":"Grimaudo","year":"1989","journal-title":"B.M.J."},{"key":"10.1007\/s10016-003-0080-4_bib11","first-page":"124","article-title":"Warfarin-induced skin necrosis in 2 patients with protein S deficiency: successful reinstatement of warfarin therapy","volume":"2","author":"Anderson","year":"1992","journal-title":"Haemostasis"},{"key":"10.1007\/s10016-003-0080-4_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0049-3848(87)90173-3","article-title":"Hereditary ATIII deficiency and atypical localization of warfarin necrosis [letter]","volume":"45","author":"Kiehl","year":"1987","journal-title":"Thromb. Res."},{"key":"10.1007\/s10016-003-0080-4_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<117::AID-AJH9>3.0.CO;2-X","article-title":"Reinstituting warfarin in patients who develop warfarin skin necrosis","volume":"52","author":"Jillella","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1007\/s10016-003-0080-4_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1007\/s10016-003-0080-4_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0954-6820.1954.tb01741.x","article-title":"Local haemorrhage and necrosis of the skin and underlying tissues, during anti-coagulant therapy with dicumarol or dicumacyl","volume":"148","author":"Verhagen","year":"1954","journal-title":"Acta Med. Scand."},{"key":"10.1007\/s10016-003-0080-4_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1378\/chest.99.4.97S","article-title":"The pharmacology of aspirin, heparin, warfarin, and thrombolytic agents: implications for therapeutic use in cardiopulmonary disease","volume":"99S","author":"Kessler","year":"1991","journal-title":"Chest"},{"issue":"S7","key":"10.1007\/s10016-003-0080-4_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00003495-199600527-00004","article-title":"New data on the pharmacology of heparin and low molecular weight heparins","volume":"52","author":"Samama","year":"1996","journal-title":"Drugs"},{"key":"10.1007\/s10016-003-0080-4_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","article-title":"Low molecular weight heparin","volume":"79","author":"Hirsh","year":"1992","journal-title":"Blood"},{"key":"10.1007\/s10016-003-0080-4_bib19","first-page":"184","article-title":"Raucourt E de, Talbot JC, et al. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan. Biochim. Biophys","volume":"1387","author":"Mauray","year":"1998","journal-title":"Acta"},{"key":"10.1007\/s10016-003-0080-4_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0049-3848(97)00079-0","article-title":"Enoxaparin, a low-molecular-weight heparin suppresses prothrombin activation more effectively than unfractionated heparin in patients treated for venous thromboembolism","volume":"86","author":"Grosset","year":"1997","journal-title":"Thromb. Res."},{"key":"10.1007\/s10016-003-0080-4_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","article-title":"Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor","volume":"97","author":"Xiao","year":"1998","journal-title":"Circulation"},{"key":"10.1007\/s10016-003-0080-4_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1345\/aph.16450","article-title":"Low-molecular-weight heparins in the treatment of deep-vein thrombosis","volume":"32","author":"Martineau","year":"1998","journal-title":"Ann. Pharmacother."},{"key":"10.1007\/s10016-003-0080-4_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000637-199502000-00017","article-title":"Warfarin-induced necrosis of the skin","volume":"34","author":"DeFranzo","year":"1995","journal-title":"Ann. Plast. Surg."},{"key":"10.1007\/s10016-003-0080-4_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/106002809703100310","article-title":"Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies","volume":"31","author":"Tonn","year":"1997","journal-title":"Ann. Pharamacother."},{"key":"10.1007\/s10016-003-0080-4_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199807093390207","article-title":"Pulmonary embolism","volume":"339","author":"Goldhaber","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1007\/s10016-003-0080-4_bib26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V84.3.815.815","article-title":"Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S","volume":"84","author":"de Frutos","year":"1994","journal-title":"Blood"},{"key":"10.1007\/s10016-003-0080-4_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.2830370313","article-title":"Warfarin skin necrosis: recurrence in the absence of anticoagulant therapy","volume":"37","author":"Humphries","year":"1991","journal-title":"Am. J. Hematol."},{"key":"10.1007\/s10016-003-0080-4_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archinte.159.1.46","article-title":"A randomized trial comparing 5-mg and 10-mg warfarin loading doses","volume":"159","author":"Crowther","year":"1999","journal-title":"Arch. Intern. Med."}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509606611278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509606611278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T22:57:09Z","timestamp":1585781829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509606611278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0890509606611278"],"URL":"https:\/\/doi.org\/10.1007\/s10016-003-0080-4","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}